ALDMS.PA Diagnostic Medical Systems SA

Healthcare Health Care Equipment & Supplies Euronext Paris
0.9100 EUR
Close of Nov 8, 2026
0.8200 1.49
Market cap
EUR 23.6M
P/E
45.5x
P/B
1.20x
ROE
8.1%
Dividend yield
-
Fundamental score
1.3/5

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is ALDMS.PA undervalued?

Graham number
Price0.9100
Graham value0.5836
Premium55.9%

ALDMS.PA trades 55.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Diagnostic Medical Systems SA fundamental analysis

3 of 11 checks passed

ROE 0/2

The stock's ROE indicates a negative return (-38.73%) on shareholders' equity, suggesting poor financial performance.

ROA 0/2

The stock's ROA (-14.41%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

PBV 2/2

The stock's low PBV ratio (0x) suggests it's undervalued, making it an attractive opportunity for investors.

DER 1/2

The stock maintains a fair debt to equity ratio (90%), indicating a reasonable balance between the money it owes and the ownership it possesses.

Revenue Growth 0/2

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

Net Profit Growth 0/2

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

Assets Growth 2/2

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

Graham Number 0/1

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

Dividend Growth 0/2

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

Dividend 0/2

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

Buffet Intrinsic Value 0/1

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Diagnostic Medical Systems SA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Diagnostic Medical Systems SA

Diagnostic Medical Systems S.A. designs, develops, manufactures, and sells medical imaging systems in France. The company offers ADAM, a software suite for imaging experts; R and F solutions, including Platinum Neo, Platinum Flex, and Optima; bone densitometers, including Stratos and Medix Series; MISTRAL, a manual chest and bone solution; and Camargue series which offers motorized radiographic systems to perform all types of bone and chest exams, including full spine and lo…

Full company profile